The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
